We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XEC
601
DELISTED
CIMAREX ENERGY CO
XEC
$1.37M 0.01%
26,178
-4,347
-14% -$202K
UHS icon
602
Universal Health Services
UHS
$9.64B
$1.37M 0.01%
9,559
-16,500
-63% -$2.35M
WDR
603
DELISTED
Waddell & Reed Financial, Inc.
WDR
$1.37M 0.01%
81,900
-50,045
-38% -$816K
JBL icon
604
Jabil
JBL
$32.6B
$1.37M 0.01%
33,142
+33,078
+51,684% +$1.27M
PAGP icon
605
Plains GP Holdings
PAGP
$5.16B
$1.34M 0.01%
70,960
-16,873
-19% -$317K
MIDD icon
606
Middleby
MIDD
$6.15B
$1.34M 0.01%
12,256
+1,000
+9% +$115K
NGL icon
607
NGL Energy Partners
NGL
$1.87B
$1.33M 0.01%
116,961
+18,665
+19% +$208K
WLKP icon
608
Westlake Chemical Partners
WLKP
$770M
$1.31M 0.01%
49,582
+5,800
+13% +$133K
CRBN icon
609
iShares Low Carbon Optimized MSCI ACWI ETF
CRBN
$1.14B
$1.3M 0.01%
10,080
+415
+4% +$51.8K
DEI icon
610
Douglas Emmett
DEI
$2.03B
$1.3M 0.01%
29,722
+29,200
+5,594% +$1.26M
UBER icon
611
Uber
UBER
$139B
$1.3M 0.01%
43,684
+43,454
+18,893% +$1.29M
WELL icon
612
Welltower
WELL
$175B
$1.3M 0.01%
15,863
+3,654
+30% +$313K
WRK
613
DELISTED
WestRock Company
WRK
$1.29M 0.01%
30,222
-2,975
-9% -$116K
CHTR icon
614
Charter Communications
CHTR
$15.7B
$1.29M 0.01%
2,657
+18
+0.7% +$8.28K
IVZ icon
615
Invesco
IVZ
$13.3B
$1.27M 0.01%
70,692
-27,345
-28% -$466K
STZ icon
616
Constellation Brands
STZ
$22.2B
$1.26M 0.01%
6,659
+1,730
+35% +$327K
IPG
617
DELISTED
Interpublic Group of Companies
IPG
$1.26M 0.01%
54,708
+17,100
+45% +$376K
FTS icon
618
Fortis
FTS
$29.7B
$1.26M 0.01%
30,295
+3,425
+13% +$140K
EXPO icon
619
Exponent
EXPO
$3.04B
$1.25M 0.01%
18,104
-494
-3% -$32.6K
CPRI icon
620
Capri Holdings
CPRI
$1.82B
$1.25M 0.01%
32,699
-563
-2% -$19.4K
PXF icon
621
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.84B
$1.24M 0.01%
29,080
+2,699
+10% +$111K
BCPC
622
Balchem Corp
BCPC
$5.29B
$1.24M 0.01%
12,154
+619
+5% +$62.4K
IEX icon
623
IDEX
IEX
$16.6B
$1.23M 0.01%
7,162
-78
-1% -$12.6K
CVSA
624
Covista Inc
CVSA
$4.09B
$1.22M 0.01%
34,991
+34,933
+60,229% +$1.2M
LYB icon
625
LyondellBasell Industries
LYB
$18.9B
$1.21M 0.01%
12,811
-1,615
-11% -$148K

Similar funds

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.